Liver diseases

Liver diseases

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Linked to Preventable Liver Mortality in the US

A significant portion of premature liver mortality in the US is attributed to metabolic dysfunction-associated steatotic liver disease (MASLD), with a substantial portion of these deaths estimated to be preventable. According to a recent study, the highest burdens of preventable MASLD-related premature liver mortality (MASLD-PLM) are found in rural, socioeconomically

Liver diseases

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Linked to Preventable Liver Mortality in the US

A significant portion of premature liver mortality in the US is attributed to metabolic dysfunction-associated steatotic liver disease (MASLD), with a substantial portion of these deaths estimated to be preventable. According to a recent study, the highest burdens of preventable MASLD-related premature liver mortality (MASLD-PLM) are found in rural, socioeconomically

Liver diseases

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Linked to Preventable Liver Mortality in the US

A significant portion of premature liver mortality in the US is attributed to metabolic dysfunction-associated steatotic liver disease (MASLD), with a substantial portion of these deaths estimated to be preventable. According to a recent study, the highest burdens of preventable MASLD-related premature liver mortality (MASLD-PLM) are found in rural, socioeconomically

Liver diseases

Real-World Work Productivity Impaired in People with Metabolic Dysfunction-Associated Steatotic Liver Disease

Recent research has shed light on the impact of metabolic dysfunction-associated steatohepatitis (MASH) on patient-reported outcomes, specifically work productivity. A study published in the journal JHEP Reports found that work productivity is impaired in people with MASH, with a significant difference in activity impairment scores between high-risk and low-risk patients.